| |
| |
|
| Insider
Information: |
Weyer Christian |
| Relationship: |
See Remarks, Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,429 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$126,280 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,429 |
|
|
| Total
Value |
$126,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Research & Develo... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Fate Therapeutics Inc |
FATE |
See Remarks, Director |
2015-04-13 |
30,429 |
2014-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FATE |
Fate Therapeutics Inc |
See Remarks |
• • – |
2015-04-13 |
4 |
OE |
$1.37 |
$34,250 |
D/D |
25,000 |
30,429 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
See remarks |
• • – |
2015-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,429 |
5,429 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
See remarks |
• • – |
2014-04-02 |
4 |
AS |
$9.02 |
$20,395 |
D/D |
(2,262) |
0 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
See remarks |
• • – |
2014-04-02 |
4 |
OE |
$1.37 |
$3,099 |
D/D |
2,262 |
2,262 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
See remarks |
• • – |
2014-04-01 |
4 |
OE |
$1.37 |
$10,601 |
D/D |
7,738 |
7,738 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
See remarks |
• • – |
2014-04-01 |
4 |
AS |
$9.02 |
$69,789 |
D/D |
(7,738) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & DevelopmentSVP |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$299,832 |
I/I |
(9,672) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & DevelopmentSVP |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$1,060,405 |
D/D |
(34,207) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & DevelopmentSVP |
• – – |
2012-07-25 |
4 |
A |
$14.62 |
$570 |
D/D |
39 |
34,207 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & DevelopmentSVP |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,529 |
7,974 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & DevelopmentSVP |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
34,168 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & DevelopmentSVP |
• – – |
2012-03-01 |
4 |
S |
$17.11 |
$21,062 |
D/D |
(1,231) |
24,168 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & Development |
• – – |
2012-02-23 |
4 |
S |
$17.03 |
$42,899 |
D/D |
(2,519) |
24,597 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & Development |
• – – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
27,116 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & Development |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
24,259 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & Development |
• – – |
2012-02-08 |
4 |
S |
$16.62 |
$63,853 |
D/D |
(3,843) |
20,416 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & Development |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,630 |
6,445 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & Development |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
13,483 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Research & Development |
• – – |
2010-11-19 |
4 |
S |
$13.42 |
$17,634 |
D/D |
(1,314) |
3,357 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr. VP Research & DevelopmentO |
• – – |
2010-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,326 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr. VP Research & DevelopmentO |
• – – |
2010-06-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,815 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
